The latest announcement is out from Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H ( ($HK:1276) ). Jiangsu Hengrui Pharmaceuticals Co., Ltd.
TipRanks on MSN
Vistin Pharma to Announce Q3 2025 Financial Results
Vistin Pharma ASA ( ($DE:VP4) ) has shared an announcement. Vistin Pharma ASA announced it will release its third quarter and ...
Vistin Pharma ASA (VISTN) will release its third quarter and YTD 2025 results on Friday 31st of October 2025. Vistin Pharma will host a conference call for all shareholders and interested parties on ...
The Subject Expert Committee (SEC), functioning under the Central Drugs Standard Control Organisation (CDSCO), has granted ...
Citing that there is a concern of the risk of genital mycosis and urinary tract infection (UTI) with Empagliflozin, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback